Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
25-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Neurocrine Biosciences Inc 41 $471.50 View Abstract
24-May-13 New Constructs, LLC N/A NBIX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
24-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NEUROCRINE BIOSCIENCES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ANIK , ABIO , GNVC , LXRX , NBIX -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for NBIX 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala NEUROCRINE BIOSCIENCES INC (NBIX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 S&P Capital IQ – STARS Reports N/A Neurocrine Biosciences 10 $115 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala NEUROCRINE BIOSCIENCES INC (NBIX) 12-months forecast 1 $15 View Abstract
Next 9

Independent Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price More Info
25-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Neurocrine Biosciences Inc 41 $471.50 View Abstract
24-May-13 New Constructs, LLC N/A NBIX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
24-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NEUROCRINE BIOSCIENCES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ANIK , ABIO , GNVC , LXRX , NBIX -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for NBIX 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala NEUROCRINE BIOSCIENCES INC (NBIX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 S&P Capital IQ – STARS Reports N/A Neurocrine Biosciences 10 $115 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala NEUROCRINE BIOSCIENCES INC (NBIX) 12-months forecast 1 $15 View Abstract
Next 9

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.